Chinese security officials announced that executives from UK drug giant GlaxoSmithKline had admitted to “serious” corruption and tax offences. Above, Reuters reports that GSK is finding unlikely defenders among Chinese netizens.
Some background on the case from the Guardian:
The allegations, which the ministry classified as “serious economic crimes”, include the bribing of doctors and officials in order to “open new sales channels and increase drug revenues”. The employees are also claimed to have used fake receipts to violate tax regulations, according to a statement on the ministry’s website. It did not reveal the employees’ identities, how many were detained or when they were questioned.
“After initial questioning the suspects have admitted to the crimes, and the investigation is ongoing,” the statement said, adding that police were carrying out investigations in Shanghai, Zhengzhou and Changsha, where GSK employees – whose identities have not been revealed – were detained two weeks ago on charges of fraud.
A spokesman for GSK rejected the charges, saying: “We take all allegations of bribery and corruption seriously. We continuously monitor our businesses to ensure they meet our strict compliance procedures. We have done this in China and found no evidence of bribery or corruption of doctors or government officials. However, if evidence of such activity is provided we will act swiftly on it.”